Analysis of anchor residues in a naturally processed HLA-DR53 ligand

Immunogenetics

Volumn 44, Issue 5, 1996, Pages 366-371

  Kobayashi, Hiroya ^a   Kokubo, Taku ^a   Abe, Yusuke ^a   Sato, Keisuke ^a   Kimura, Shoji ^a   Miyokawa, Naoyuki ^a   Katagiri, Makoto ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN;

ARTICLE; AUTOIMMUNITY; BINDING AFFINITY; FLOW CYTOMETRY; HUMAN; L CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029831482     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02602781     Document Type: Article

References (18)

1. Brown, J. H., Jardetzky, T. S., Gorga, J. C., Stern, L. J., Urban, R. G., Strominger, J. L., and Wiley, D. C. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364: 33-39, 1993
2. Busch, R., Hill, C. M. Hayball, J. D., Lamb, J. R., and Rothbard, J. B. Effect of natural polymorphism at residue 86 of the HLA-DR β chain on peptide binding. J Immunol 147: 1292-1298, 1991
3. Chicz, R. M., Urban, R. G., Gorga, J. C., Vignali, D. A. A., Lane, W. S., and Stominger, J. L. Specificity and promiscuity among naturally processed peptides hound to HLA-DR allele. J Exp Med 178: 27-47, 1993
4. Davenport, M. P., Quinn, C. L., Chicz, R. M., Green, B. N., Willis, A. C., Lane, W. S., Bell, J. L. and Hill, A. V. S. Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DRβ chain. Proc Natl Acad Sci USA 92: 6657-6571, 1995
5. Dong, R.-P., Kamikawaji, N., Toida, N., Fujita, Y., Kimura, A., and Sasazuki, T. Characterization of T cell epitope restricted by HLA-DP9 is treptococcal M12 protein. J Immunol 154: 4536-4545, 1995
6. Futaki, G., Kobayashi, H., Sato, K., Taneichi, M., and Katagiri, M. Naturally processed HLA-DR9/DR53 (DRB1*0901/DRB4*0101)-bound peptides. Immunogenetics 42: 299-301, 1995
7. Hammer, J., Valsasnini, P., Tolba, K., Bolin, D., Higelin, J., Takacs, B., and Sinigaglia. F. Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell 74: 197-203, 1993
8. Hammer, J., Takacs, B., and Sinigaglia, F. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J Exp Med 176: 1007-1013, 1992
9. + T cells specific to streptococcal antigen present in low but not in high responders. J Immunol 146: 2560-2567, 1991
10. Kinouchi, R. and Katagiri, M. Analysis of naturally processed peptides bound to HLA-DR4, DR53 (DRB1*0405, DRB4*0101). Hokkaido J Med Sci 70: 175-181, 1995
11. Moriuchi, J., Katagiri, M., Wakisaka, A., Ikeda, H., Maruyama, N., Tagawa, Y., Aizawa, M., and Itakura, K. Association of B-cell alloantigenic determinant, Hon 7, with Harada's disease. Immunogenetics 9: 487-489, 1979
12. Mozes, E., Dayan, M., Zisman, E., Brocke, S., Licht, A., and Pecht, I. Direct binding of a myasthenia gravis related epitope to MHC class II molecules on living murine antigen-presenting cells. EMBO J 8: 4049-4052, 1989
13. Newcomb, J. R. and Cresswell, P. Characterization of endogeneous peptides bound to purified HLA-DR molecules and their absence from invariant chain-asociated α β dimers. J Immunol 150: 499-507, 1993
14. Rammensee, H.-G., Friede, T., Stevanović, S. MHC ligands and peptide motifs: first listing. Immunogenetics 41: 178-228, 1995
15. Rothbard, B. J., and Gefter, M. L. Interactions between immunogenic peptides and MHC proteins. Annu Rev Immunol 9: 527-565, 1991
16. Shackelford, D. A., Lampson, L. A., and Strominger, J. L. Analysis of HLA-DR antigen by using monoclonal antibodies: recognition of conformational differences in biosynthetic intermediates. J Immunol 127: 1403-1410, 1981
17. Stern, L., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L., and Wiley, D. C. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368: 215-221, 1994
18. Van der Burg, S. H., Ras, E., Drijfhout, J. W., Benckhuijsen, W. E., Bremers, A. J. A., Melief, C. J. M., and Kast, W. M. An HLA class I peptide-binding assay based on competition tor binding to class I molecules on intact human B cells. Hum Immunol 44: 189-198, 1995